Close Menu

NEW YORK (GenomeWeb) – NeoGenomics said after the close of the market on Tuesday that is has priced its previously announced underwritten public offering of 7 million shares of its common stock at a public offering price of $21.25 per share.

Gross proceeds to NeoGenomics from the offering are expected to be $148.8 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
19
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.